Assyro AI

Orange Book product · Brand (NDA)

TRUDHESA

DIHYDROERGOTAMINE MESYLATE

Brand (NDA)NDA 213436RX IMPEL PHARMS

At a glance

Sep 02, 2021

Approved

Brand (NDA)

Application

Not listed

TE code

6

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Sep 02, 2021

    4 yr 10 mo ago

  2. Today

  3. Patent 9550036 expires

    Listed drug product patent expiration.

    Sep 05, 2032

    in 6 yr 4 mo

  4. Patent 10507295 expires

    Listed drug product patent expiration.

    Dec 25, 2032

    in 6 yr 7 mo

  5. Patent 10940278 expires

    Listed drug product patent expiration.

    Jan 23, 2033

    in 6 yr 8 mo

  6. Patent 9919117 expires

    Listed drug product patent expiration.

    Mar 17, 2033

    in 6 yr 10 mo

  7. Patent 11266799 expires

    Listed drug product patent expiration.

    Nov 05, 2036

    in 10 yr 6 mo

  8. Patent 11185497 expires

    Listed method-of-use patent (U-3218) expiration.

    Jan 04, 2039

    in 12 yr 9 mo

Pharmaceutical detail

Active ingredient

DIHYDROERGOTAMINE MESYLATE

Strength

0.725MG/SPRAY

Dosage form

SPRAY, METERED

Route

NASAL

TE code

Not listed

Application

NDA 213436

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (6)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9550036Sep 05, 2032in 6 yr 4 mo
Product
10507295Dec 25, 2032in 6 yr 7 mo
Product
10940278Jan 23, 2033in 6 yr 8 mo
Product
9919117Mar 17, 2033in 6 yr 10 mo
ProductU-3218
11266799Nov 05, 2036in 10 yr 6 mo
Product
11185497Jan 04, 2039in 12 yr 9 mo
U-3218
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.